Web Analytics

3 Latest Announced Rounds

  • $2,500,000
    Unknown

    1 Investors

    Services for Renewable Energy
    Nov 22nd, 2024
  • $1,447,585
    Seed
    Design Services
    Nov 22nd, 2024
  • $45,000,000
    Series C

    1 Investors

    Renewable Energy Semiconductor Manufacturing
    Nov 22nd, 2024
$1,939.23M Raised in 89 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Latigo Biotherapeutics, Inc.

start up
United States - Thousand Oaks, CA
  • 15/02/2024
  • Series A
  • $135,000,000

Latigo Biotherapeutics Inc., headquartered in Thousand Oaks, CA, is a privately held clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target the fundamental mechanism of pain transduction. The company’s proprietary, in-house technology generates novel drugs against targets validated by human genetics using the most advanced artificial intelligence, machine learning, structure-based, and knowledge-based design techniques to optimize potency and selectivity. The company is backed by top-tier investors, including Westlake Village BioPartners, 5AM Ventures, Foresite Capital, and Corner Ventures.


Related People

Desmond PadhiFounder

Desmond Padhi United States - Westlake Village, California

N/A